Who founded Genecis Bio?

Genecis Bio was founded by Luna Yu in 2017.

Who are Genecis Bio's investors?

Genecis Bio's investors include Allied Venture Partners, Asymmetry Ventures, Beresford Ventures, Celtic House Asia Partners, Emerald Technology Ventures Ag, Helium-3 Ventures, Y Combinator.

Where is Genecis Bio headquartered?

Genecis Bio is headquartered in Toronto, CA.

Genecis Bio

YC W20

Toronto, CA · Founded 2017 · 30 employees · 7 known investors

Genecis commercializes the production of polyhydroxyalkanoate (PHA), a biodegradable polymer made from bacteria that consume organic waste, offering a sustainable alternative to petroleum-based plastics for packaging, textiles, medical devices, and other applications. The company applies circular economy principles to create high-quality, eco-friendly products that break down naturally without microplastic pollution.

Also known as Genecis Bioindustries · Genecis Bioindustries Inc.

Advanced Manufacturing Biotech Circular Economy Cleantech Climate Tech Robotics Bioplastic Synthetic Biology Climate ClimateTechCanadaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W20)

Genecis Bio was founded in 2017 by Luna Yu.

Luna YuinFounder

Investors · 7

Allied Venture PartnersCalgary · $100K – $350K

Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred

Beresford VenturesOrlando

Celtic House Asia PartnersToronto

Emerald Technology Ventures AgZurich · $540K – $5.4M

Helium-3 VenturesNew York

Y CombinatorSan Francisco · $500K

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AAug 2022
BDC Capital’s Cleantech Practice (lead), Khosla Ventures (lead), AME Cloud Ventures, Gullspang Re:food, Heinz Group, IT Farm
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

eGenesis5 shared keywordseGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.

Orgenesis3 shared keywordsOrgenesis operates the POCare Platform for developing, scaling, and commercializing advanced cell and gene therapies delivered at the point of care. It works with academia, research institutes, and hospitals to bring these therapies to patients globally.

Companies competing with Genecis Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Genecis Bioindustries raises $10M to commercialize bioplastics products - Canadian Biomass Magazinecanadianbiomassmagazine.ca · Aug 2022

Genecis secures $10m to commercialise biodegradable plastic productsnspackaging.com · Aug 2022

Frequently asked questions

What does Genecis Bio do?: Genecis commercializes the production of polyhydroxyalkanoate (PHA), a biodegradable polymer made from bacteria that consume organic waste, offering a sustainable alternative to petroleum-based plastics for packaging, textiles, medical devices, and other applications. The company applies circular economy principles to create high-quality, eco-friendly products that break down naturally without microplastic pollution.
Who founded Genecis Bio?: Genecis Bio was founded by Luna Yu in 2017.
Who are Genecis Bio's investors?: Genecis Bio's investors include Allied Venture Partners, Asymmetry Ventures, Beresford Ventures, Celtic House Asia Partners, Emerald Technology Ventures Ag, Helium-3 Ventures, Y Combinator.
Where is Genecis Bio headquartered?: Genecis Bio is headquartered in Toronto, CA.